Month archive: August, 2019

Webinar – Health workers on the move: possibilities and perspectives ten years into the WHO Code. A civil society perspective

On August 19th, the Health Workers For All Coalition – which Wemos co-chairs – held a webinar. During this webinar, Wemos’ global health advocate Corinne Hinlopen and Genevieve Gencianos of Public Services International shared their insights on the ongoing review of the WHO Code of Practice on the International Recruitment of Health Personnel.

Continue reading

Wemos in De Telegraaf: subsidies have made Zolgensma and its high price possible

1.9 million Euro. It is expected that that will be the price of the medicine Zolgensma, manufactured by the pharmaceutical company Novartis. At the end of this month, the European Medicines Agency (EMA) will give approval for this medicine. The Dutch newspaper De Telegraaf recently interviewed our global health advocate Ella Weggen about how the current medicines policy in the Netherlands has made the ludicrously high price of 1.9 million Euro possible.

Continue reading